Vistagen Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 02/17/2026 | 3.06 M | $2.03 M | 0.00% | 7.25% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 2.68 M | $1.77 M | 0.00% | 6.34% |
| VANGUARD GROUP INC | 01/29/2026 | 1.82 M | $1.21 M | 8.12% | 4.32% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 623.58 K | $412.74 K | 451.53% | 1.48% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 616.75 K | $142.09 K | -75.22% | 1.46% |
| JANE STREET GROUP, LLC | 02/12/2026 | 527.13 K | $348.91 K | 74.15% | 1.25% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 519.08 K | $343.58 K | -16.40% | 1.23% |
| CITADEL ADVISORS LLC | 02/17/2026 | 465.10 K | $307.85 K | 367.44% | 1.10% |
| BLACKROCK, INC. | 02/12/2026 | 422.76 K | $279.82 K | -0.09% | 1.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 415.40 K | $274.16 K | 79.59% | 0.98% |
| CITADEL ADVISORS LLC | 02/17/2026 | 386.60 K | $255.89 K | 59.36% | 0.92% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 352.84 K | $233.61 K | 18.29% | 0.84% |
| LUMINUS MANAGEMENT LLC | 02/17/2026 | 350.00 K | $231.67 K | 100.00% | 0.83% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 334.79 K | $221.60 K | 291.13% | 0.79% |
| ADVISORSHARES INVESTMENTS LLC | 02/10/2026 | 250.19 K | $165.60 K | 20.86% | 0.70% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 197.05 K | $130.42 K | 853.01% | 0.47% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 195.57 K | $129.45 K | -32.42% | 0.46% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 151.87 K | $100.63 K | 123.29% | 0.42% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 160.79 K | $106.43 K | -61.90% | 0.38% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 137.73 K | $91.17 K | -12.29% | 0.33% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 134.57 K | $89.07 K | -31.70% | 0.32% |
| STATE STREET CORP | 02/13/2026 | 121.11 K | $80.17 K | 25.04% | 0.29% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 120.00 K | $79.43 K | 100.00% | 0.28% |
| DIADEMA PARTNERS LP | 02/17/2026 | 106.50 K | $70.49 K | 6.29% | 0.25% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 106.14 K | $70.25 K | 266.90% | 0.25% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 103.40 K | $68.44 K | 100.00% | 0.24% |
| DIADEMA PARTNERS LP | 02/17/2026 | 100.00 K | $66.19 K | -71.41% | 0.24% |
| JANE STREET GROUP, LLC | 02/12/2026 | 79.70 K | $52.75 K | 100.00% | 0.19% |
| TUDOR INVESTMENT CORP ET AL | 02/17/2026 | 76.17 K | $50.42 K | 100.00% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 75.00 K | $49.50 K | 417.24% | 0.18% |
| NORTHERN TRUST CORP | 02/17/2026 | 72.66 K | $48.09 K | 51.07% | 0.17% |
| 04/02/2026 | 62.70 K | $41.50 K | 100.00% | 0.15% | |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 61.40 K | $40.64 K | 100.00% | 0.15% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 60.14 K | $39.81 K | 100.00% | 0.14% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 02/17/2026 | 59.04 K | $39.08 K | 38.25% | 0.14% |
| UBS GROUP AG | 01/29/2026 | 51.99 K | $34.42 K | 102.57% | 0.12% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 48.77 K | $32.28 K | 18.74% | 0.12% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 45.20 K | $29.92 K | 0.00% | 0.11% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 37.74 K | $25.00 K | 100.00% | 0.09% |
| HRT FINANCIAL LP | 02/12/2026 | 37.59 K | $24.00 K | 100.00% | 0.09% |
| ENGINEERS GATE MANAGER LP | 02/17/2026 | 30.49 K | $20.18 K | 100.00% | 0.07% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 23.30 K | $15.42 K | 0.00% | 0.07% |
| PERSISTENT ASSET PARTNERS LTD | 02/17/2026 | 26.61 K | $17.61 K | -64.67% | 0.06% |
| KESTRA ADVISORY SERVICES, LLC | 02/13/2026 | 26.03 K | $17.23 K | 29.95% | 0.06% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 20.63 K | $13.65 K | -0.96% | 0.06% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 21.74 K | $14.39 K | 99.72% | 0.05% |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | 02/17/2026 | 20.58 K | $13.62 K | 100.00% | 0.05% |
| SHAY CAPITAL LLC | 02/17/2026 | 20.20 K | $13.37 K | 100.00% | 0.05% |
| MARSHALL WACE, LLP | 02/13/2026 | 19.97 K | $13.18 K | 100.00% | 0.05% |
| TRUVESTMENTS CAPITAL LLC | 02/13/2026 | 16.99 K | $11.25 K | 96.33% | 0.04% |
Vistagen Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 74 institutional investors and hedge funds held shares of Vistagen Therapeutics Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 3.06 M
TCG Crossover Management, LLC: 2.68 M
VANGUARD GROUP INC: 1.82 M
ADAR1 Capital Management, LLC: 623,575
StemPoint Capital LP: 616,749
JANE STREET GROUP, LLC: 527,127
32.56% of Vistagen Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 14.22 M shares in the last 24 months. This purchase volume represents approximately $8.82 M in transactions.